Rapid Micro Biosystems, Inc. (RPID)

Market Cap	48.12M
Revenue (ttm)	20.56M
Net Income (ttm)	-57.74M
Shares Out	37.09M
EPS (ttm)	-1.34
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53,853
Open	1.10
Previous Close	1.12
Day's Range	1.04 - 1.15
52-Week Range	0.83 - 1.89
Beta	1.30
Analysts	Hold
Price Target	2.75 (+140.18%)
Earnings Date	Nov 3, 2023

About RPID

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual micro...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 15, 2021
• Employees: 177
• Stock Exchange: NASDAQ
• Ticker Symbol: RPID

Financial Performance

In 2022, RPID's revenue was $17.13 million, a decrease of -26.25% compared to the previous year's $23.23 million. Losses were -$60.81 million, -22.08% less than in 2021.

Analyst Forecast

According to one analyst, the rating for RPID stock is "Hold" and the 12-month stock price forecast is $2.75.

Price Target

$2.75

(140.18% upside)

Analyst Consensus: Hold